We are live on ! Find out more
PLRX icon

Pliant Therapeutics
PLRX

37 hedge funds and large institutions have $877M invested in Pliant Therapeutics in 2020 Q2 according to their latest regulatory filings, with 37 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

79.7% more ownership

Funds ownership: 0% → 79.7% (+80%)

Holders
37
Holders Change
+37
Holders Change %
–
% of All Funds
0.76%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
% of All Funds
0.08%
New
37
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
TGI
TRV GP III
Massachusetts
+$155M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$142M
3
RG
Redmile Group
California
+$90.5M
4
EAM
Eventide Asset Management
Massachusetts
+$75.3M
5
CA
CHI Advisors
New York
+$61.2M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
TGI
1
TRV GP III
Massachusetts
$190M +$155M +5,839,160 New
Fidelity Investments
2
Fidelity Investments
Massachusetts
$173M +$142M +5,332,701 New
RG
3
Redmile Group
California
$111M +$90.5M +3,410,657 New
EAM
4
Eventide Asset Management
Massachusetts
$88.4M +$75.3M +2,838,125 New
CA
5
CHI Advisors
New York
$74.9M +$61.2M +2,305,994 New
TGI
6
TRV GP IV
Massachusetts
$69.2M +$56.6M +2,132,867 New
Citadel Advisors
7
Citadel Advisors
Florida
$40M +$32.7M +1,232,780 New
FCM
8
Farallon Capital Management
California
$27.6M +$22.6M +850,801 New
CAM
9
Cormorant Asset Management
Massachusetts
$18.8M +$16.2M +611,409 New
HMC
10
Harvard Management Company
Massachusetts
$18.3M +$14.9M +562,379 New
Bessemer Group
11
Bessemer Group
New Jersey
$17.4M +$14.3M +537,379 New
LGM
12
Logos Global Management
California
$14.6M +$12.1M +456,426 New
Franklin Resources
13
Franklin Resources
California
$8.92M +$9.29M +350,000 New
SCM
14
Suvretta Capital Management
New York
$3.07M +$2.51M +94,700 New
ZP
15
Zimmer Partners
New York
$2.78M +$2.28M +85,741 New
BlackRock
16
BlackRock
New York
$2.77M +$2.27M +85,487 New
PAMU
17
Pictet Asset Management (UK)
United Kingdom
$2.6M +$2.12M +80,000 New
Alyeska Investment Group
18
Alyeska Investment Group
Illinois
$2.29M +$1.87M +70,560 New
Millennium Management
19
Millennium Management
New York
$2.27M +$1.86M +70,068 New
Goldman Sachs
20
Goldman Sachs
New York
$1.46M +$1.19M +45,000 New
PCM
21
Pentwater Capital Management
Florida
$1.31M +$1.07M +40,500 New
MWNA
22
Marshall Wace North America
New York
$1.26M +$1.03M +38,825 New
MIM
23
Monashee Investment Management
Massachusetts
$1.17M +$955K +36,000 New
CCM
24
CAAS Capital Management
New York
$812K +$664K +25,000 New
Vanguard Group
25
Vanguard Group
Pennsylvania
$812K +$664K +25,000 New
1
2

PLRX Hedge Fund Activity: Q2 2020 in Review

37 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Pliant Therapeutics (PLRX) for Q2 2020, worth a combined $877M.

Buyers outnumbered sellers: 37 funds opened new PLRX positions and 0 closed out — a net gain of 37 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was TRV GP III, opening a new position worth an estimated $155M.

  • 37 institutional investors held Pliant Therapeutics (PLRX) as of Q2 2020, up from 0 in Q1 2020.
  • Funds reported $877M of Pliant Therapeutics stock for Q2 2020.
  • 37 funds opened new Pliant Therapeutics positions in Q2 2020 and 0 closed out, a net change of +37 holders.
  • The largest Pliant Therapeutics buyer in Q2 2020 was TRV GP III, an estimated $155M added.

Based on aggregated 13F filings for Q2 2020.